# Sofgen Pharma S.A. (PROCF)

> Healthcare · LU · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PROCF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 458.18M | $ 43.62M | $ 56.74M | $ 299.50M | $ 210.0K |
| 2022 | $ 362.27M | $ 29.15M | $ -16.50M | $ 287.07M | $ -36.20M |
| 2021 | $ 487.04M | $ -207.75M | $ 54.65M | $ 253.37M | $ -69.05M |
| 2020 | $ 0 | $ -1.85M | $ -389.0K | $ 0 | $ 202.23M |
| 2019 | $ 0 | $ 444.1K | $ -465.7K | $ 0 | $ 202.07M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1,426.20 |
| Liabilities / Eq | 2,253.50 |
| Current Ratio | 0.69 |

## Other views

- [Metrics](https://sponda.capital/en/PROCF.md)
- [Charts](https://sponda.capital/en/PROCF/charts.md)
- [Compare](https://sponda.capital/en/PROCF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.